Dunsire Deborah 4
4 · Syros Pharmaceuticals, Inc. · Filed Jun 4, 2024
Insider Transaction Report
Form 4
Dunsire Deborah
Director
Transactions
- Exercise/Conversion
Restricted Stock Units
2024-06-01−4,000→ 0 total→ Common Stock (4,000 underlying) - Exercise/Conversion
Common Stock
2024-06-01+4,000→ 12,000 total
Footnotes (3)
- [F1]Represents shares of common stock received upon vesting of a restricted stock unit ("RSU") award.
- [F2]Each RSU represents the contingent right to receive one share of the issuer's common stock.
- [F3]These RSUs vested in their entirety on the first anniversary of the date of grant of the award.